Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2018-06-06

Original market date: See footnote 1

1973-12-31

Lot number: See footnote 2

497581

Expiry date: See footnote 2

2017-10-31

Product name:

NOVO-RYTHRO ESTOLATE SUSPENSION

DIN:

00262595 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

08:12.12.04 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J01FA01 ERYTHROMYCIN

Active ingredient group (AIG) number:See footnote5

0105708006

List of active ingredient(s)
Active ingredient(s) Strength
ERYTHROMYCIN (ERYTHROMYCIN ESTOLATE) 250 MG / 5 ML
Version 4.0.2
Date modified: